has caused many problems for both food industries and regulatory agencies worldwide. The number of L. monocytogenes cells required to cause disease in both normal and debilitated individuals is unknown. This has created many problems from a regulatory point of view, because in some countries (the United States), it has been necessary to recall all foods containing the organism, regardless of the number of cells present.
Although there have been a number of feeding trials with L. monocytogenes by using animals such as mice (5, 17) , sheep (15) , rabbits (6, 14) , and goats (13) to determine their suitability as animals models, little work has been done by using the monkey as a model. Thus, studies were undertaken to evaluate the use of the cynomolgus monkey as an animal model and approximate the minimum infectious dose of L. monocytogenes for healthy humans.
In each experiment, four or five adult female Macaca fascicularis (cynomolgus monkeys) weighing 3 to 5 kg were used. Each animal, fed ad libitum, was housed in a separate cage, with all cages being kept in a specially designed Labsafe facility (Canadian Cabinets, Nepean, Ontario, Canada (Difco) with 0.6% yeast extract (TSB-YE). Tubes were then incubated at 30°C for 24 h, the suspension was centrifuged at 2,000 x g for 30 min, and the pellet was resuspended in sterile whole milk. Dilutions in milk were subsequently made to give total final cell concentrations of 109, 107, and 105 cells. The inoculum was administered into the stomachs of the monkeys in a total volume of 10 ml of milk with the aid of a nasogastric tube. Control monkeys included those that received 10 ml of sterile milk and/or no treatment at all. In experiments in which we looked at the effects of reduced gastric acidity on the outcome of infection, 10 ml of Maalox Plus was fed to the monkeys (nasogastric tube) 1 h prior to dosing. AUl experiments were performed in duplicate.
For the first 5 days, nasal swabs, blood samples, body temperature, the general appearance of the animal, and food consumption patterns were recorded. Fecal specimens were taken every day for 5 days and then approximately every second day for up to 30 days.
Complete hematological profiles were performed on a Coulter counter (S+IV; Coulter Counter, Burlington, Ontario, Canada). The differentials were obtained by microscopic evaluation at x400 power.
The fecal and nasal specimens were analyzed for L. monocytogenes by the method of the U.S. Department of Agriculture (10, 11) , except that University of Vermont (UVM) enrichment broths were incubated for 7 days, with 0.1 ml being transferred into Fraser broth at days 1 and 7. In addition, LPM and Oxford media were used instead of modified Oxford medium. Confirmation of L. monocytogenes was done as described previously (4).
L. monocytogenes Scott A or F6861 was grown at 25°C for 48 h in 50 ml of TSB-YE containing 1% glucose. Formaldehyde solution (final concentration, 0.5% in saline) was then added to the flasks, which were then incubated for an additional 24 h at 25°C. TA plates were streaked from the broth to check for sterility. The suspension was then centrifuged (11,000 x g, 20 min), the cells were washed twice with 0.5% formaldehyde, and the pellet was resuspended in 5 ml of 0.1 M phosphate-buffered saline solution (PBS; pH 7.0). The antigen was then frozen at -70°C in small vials until it was needed. Tests were done in small disposable glass tubes. Briefly, 0.5 ml of PBS buffer and 0.5 ml of serum were placed into the tubes, and a series of doubling dilutions was performed. The test antigen (0.5 ml), either undiluted or diluted 1:11 in PBS buffer, was added to each tube. All tubes were then placed in a water bath at 60°C for 2 h. The presence of agglutination at the bottom of the tubes was recorded visually 1 h after removal from the water bath and after overnight incubation at 4°C. Controls without serum were included to ensure that agglutination and sedimentation were clearly distinguishable. Results obtained with both strains of L. monocytogenes were similar, and thus data are given only for L. monocytogenes F6861. For the most part, symptoms were observed only in those monkeys that received the largest dose (109 cells) of L. monocytogenes. Low-grade fever (normal body temperature, 37.5 to 38.0°C), septicemia (L. monocytogenes was isolated from the blood in three of the six trials), loss of appetite, irritability and occasional diarrhea were observed. Fever peaked on the second day after dosing. The highest recorded temperature for any animal was 38.9°C. None of the animals was treated with antibiotics at any time.
Nasal specimens were almost consistently negative throughout all experiments, with the exception of the isolation of L. monocytogenes on one or two occasions (data not shown). A typical fecal shedding pattern is given in Table 1 This decrease in lymphocytes and the increase in neutrophils were much more evident in those animals that received the largest dose (109) of L. monocytogenes (Fig. 1) . Values returned to more or less normal levels by days 3 to 4 postinfection. The percent normal range of lymphocytes and neutrophils in cynomolgus monkeys would be approximately 50 to 70% and 20 to 45%, respectively (3) .
Monkeys treated with Maalox exhibited blood results, temperature profiles, and fecal shedding patterns similar to those of control monkeys (data not shown). The pH of gastric aspirates was determined whenever possible, with values in control and Maalox-treated monkeys being approximately 2.4 and 7.3, respectively. Agglutination titers on predosed monkeys ranged from 1:16 to 1:128, with most animals giving a titer of either 1:16 or 1:64. For some of the monkeys that received the 109 challenge dose, titers determined approximately 1 to 2 weeks after dosing were in the range of 1:256 to 1:512. No attempt was made to follow the agglutination titers throughout the course of infection.
In this investigation, an attempt was made to establish a minimum infectious dose for normal healthy individuals by using the cynomolgus monkey as an animal model. Listeriosis has previously been reported both in pregnant and nonpregnant adult nonhuman primates (7, 19) . In addition, a recent outbreak of listeriosis in 11 macaques housed outdoors was recently reported (16) . This outbreak caused 10 stillbirths and one case of neonatal septicemia. In that outbreak, restriction enzyme analysis pointed to a common source of contamination for the monkeys. The nature and distribution of the lesions observed in the monkeys were typical of those observed in human perinatal listeriosis (16) .
This study showed that monkeys that received a dose of 109 cells of L. monocytogenes displayed a response indicative of infection, while those that received the 107 dose did not exhibit the signs and symptoms described above, although lymphopenia and neutrophilia were observed (Fig.  1) . Results similar to those of the present study were recently seen in goats orally inoculated with 6 x 109 L. monocytogenes (13) . Four of five goats developed fever, with the highest temperatures (41.0 to 41.8°C) occurring 1 to 2 days after dosing. Poor appetite was also observed in those animals. It was interesting to observe that consistent fecal shedding occurred only in those animals that received 107 organisms. The length of shedding in these animals (ca. 21 days) was somewhat similar to that reported by Miettinen et al. (13) for goats that shed L. monocytogenes in the feces for times ranging from 3 to 15 days. The possibility of fecal to oral spread of the organism in humans would therefore be a possibility only in instances in which individuals consumed large numbers of L. monocytogenes. It was also interesting that the monkey that received a dose of109 cells for a second time did not shed the organism for as long a period oftime and did not develop the signs and symptoms typical of those found in animals that received only one dose of 109 cells. This suggests that the initial exposure to the organism led to the development of antibodies which may have been associated with the more rapid clearance of L. monocytogenes from the gastrointestinal tract and the absence of clinical symptoms. These results, suggesting the possible involvement of humoral immunity in the elimination of the infection, are very similar to those recently reported for experimentally infected goats (13) .
Our studies with Maalox-treated monkeys did not demonstrate any significant difference between treated and nontreated monkeys, although we observed a neutralization of the gastric acidity in the stomachs of the monkeys. Antacid consumption was considered a risk factor for acquisition of listeriosis in the outbreak which occurred in Boston in 1979 (8) . It was theorized that antacids neutralized gastric acidity, possibility allowing L. monocytogenes to survive ingestion (8) . Golnazarian et al. (5), working with C57BL/6J mice, also observed no significant differences in the 50% infectious dose between normal or cimetidine (which decreases gastric acid secretion)-treated mice. They felt that because the mice did not have the underlying condition that required treatment with cimetidine, the results should be interpreted with caution (5).
The numbers of ingested cells of L. monocytogenes required to cause illness in normal healthy humans has been estimated in few instances. Two sporadic cases of listeriosis involved the consumption of contaminated salted mushrooms (9) and homemade sausage (2), with both foods containing approximately 3 x 106 to 4 x 106 L. monocytogenes per g. However, it was not clear how much of the product the individuals consumed. One well-documented case of sporadic listeriosis occurred in a healthy individual who consumed contaminated soft cheese. It was estimated that this particular female consumed an oral dose of 2.5 x 109 to 4.3 x 109 L. monocytogenes, with symptoms developing less than 24 h later (1). This infection would be similar to the one we observed in the monkeys. However, it is highly likely that many other individuals, both normal and high-risk individuals, consumed this same soft cheese containing high numbers (>105 CFU/g) of L. monocytogenes without apparently developing listeriosis (12) . It is possible, however, that very mild upper gastrointestinal symptoms may have developed in some individuals, which would have gone undetected. We have fortuitously observed a case such as this in Canada, where a 59-year-old female developed a very mild case of listeriosis (no fever, septicemia, or meningitis) after consuming soft cheese containing a total of 2.7 x 106 organisms (3). In addition, in a recent listeriosis outbreak in Connecticut which was epidemiologically linked to the consumption of shrimp, the presence of mild disease was observed in the healthy hosts who consumed the contaminated food (18) .
This study focused on the development of listeriosis in healthy adult monkeys. The next phase of this study will be to use drugs to suppress the immune system of the animals. It is hoped that by doing this, it will be possible to more
